Medical lead having segmented electrode

• US 5,522,874 A
• Filed: 07/28/1994
• Issued: 06/04/1996
• Est. Priority Date: 07/28/1994
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Gates, James T.
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): Jastrzab, Jeffrey R.
• Application Number:
  US08/282,122
• Time in Patent Office: 677 Days
• Field of Search: 607/120-123, 607/125-131, 128/642
• US Class Current: 607/127
• CPC Class Codes: A61N 1/0575 with drug delivery

Abstract

A stylet-actuated, steroid-eluting, screw-in, endocardial, transvenous bipolar pacing lead. In an embodiment, the lead is provided, with a sharpened helix. Advancing and retraction of the helix is accomplished with a stylet having a flattened, screw-driver tip. Rotation of the stylet imparts rotation to the helix assembly, causing the helix to advance or retract. A segmented tip electrode having a porous coating thereon allows steroid from a monolithic controlled released device housed within the electrode assembly to be eluted at the location of the implant site.

Claims

1. An electrode assembly comprising a substantially annular electrode face having a plurality of alternating conductive and non-conductive radially-oriented segments disposed perpendicularly about a substantially circular, non-conductive central portion, the electrode face being disposed upon a distal end of the electrode assembly wherein at least one of the segments has at least one drug-elution port formed therein, and wherein the electrode assembly has a monolithic controlled release device disposed proximal to the annular face.

2. An electrode assembly in accordance with claim 1, wherein the at least one drug-elution port is disposed in at least one of the conductive segments of the annular face.

3. An electrode assembly in accordance with claim 2, wherein the conductive segments on the annular face have a porous sintered coating disposed thereon, and wherein the drug-elution port is located proximal to the porous sintered coating.

4. An electrode assembly in accordance with claim 1, further comprising:

a fixation helix rotatably disposed within the substantially circular, non-conductive central portion of the electrode;

a helix seal, rigidly disposed within the substantially circular, non-conductive central portion, the helix seal having a helical channel such that upon rotation of the fixation helix in a first direction, the helix seal guides the helix to advance distally out from the substantially circular central portion, and such that upon rotation of the fixation helix in a second direction, the helix seal guides the helix to retract proximally into the substantially circular central portion.

5. An electrode assembly in accordance with claim 4, further comprising a stylet socket coupled to the fixation helix, the stylet socket having a configuration for receiving a stylet tip therein for remote rotation of the helix.

6. A medical lead comprising:

a lead body, the lead body having a first coiled conductor;

a terminal assembly positioned on a proximal end of the lead body; and

an electrode assembly disposed at a distal end of the lead body, the electrode assembly comprising a substantially annular electrode face having a plurality of alternating conductive and non-conductive radially-oriented segments disposed about a substantially circular, non-conductive central portion, said plurality of alternating conductive radially-oriented segments coupled to the first coiled conductor.

10. A lead in accordance with claim 6, further comprising:

a fixation helix, rotatably disposed proximal to the substantially circular, non-conductive central portion of the electrode;

a helix seal, rigidly disposed within the substantially circular, non-conductive central portion of the electrode face, the helix seal having a helical channel therein for receiving at least one turn of the fixation helix, such that upon rotation of the fixation helix in a first direction, the helix seal guides the helix to advance distally out from the substantially circular central portion, and upon rotation of the fixation helix in a second direction, the helix seal guides the helix to retract proximally into the substantially circular central portion.

11. A lead in accordance with claim 10, further comprising a stylet socket, rigidly coupled to the fixation helix, the stylet socket having a configuration for receiving a stylet tip therein for remote rotation of the helix.

12. A lead in accordance with claim 11, wherein the lead body has a longitudinal lumen extending between proximal and the distal end, adapted to receive a stylet having a slotted-head tip therein and facilitate advancement of the slotted-head tip to engage the stylet socket.

7. A lead in accordance with claim 7, wherein the annular electrode face of the electrode assembly has at least one drug-elution port formed therein, and wherein the lead further includes a monolithic controlled release device disposed proximal to the annular face of the electrode.

8. A lead in accordance with claim 7, wherein the at least one drug-elution port is disposed in at least one of the conductive segments of the annular face of the electrode.

9. A lead in accordance with claim 8, wherein the conductive segments on the annular electrode face have a platinized, porous sintered coating disposed thereon and wherein the drug elution port is located proximal to the platinized, porous sintered coating.

13. A medical lead comprising:

a lead body having a first coiled conductor and a second coiled conductor, the lead body having a terminal assembly positioned on a proximal end of the lead body;

an electrode assembly disposed at a distal end of the lead body, the electrode assembly comprising a cylindrical tip electrode having a plurality of conductive radially-oriented segments disposed perpendicularly about a distal end of the cylindrical tip electrode;

a helix seal positioned within the tip electrode, the helix seal having a helical path therethrough; and

a helix assembly disposed within the lead body, the helix assembly having a socket portion and a helix extending from the socket portion through at least a portion of the helical path through the helix seal wherein a rotation of the socket portion in a first direction causes the helix to move in a first direction coaxial with the lead body and rotation of the socket portion in a second direction causes the helix to move in a second direction coaxial with the lead body.

14. A lead in accordance with claim 13, wherein at least one of the plurality of conductive radially-oriented segments disposed perpendicularly about the distal end of the tip electrode has a drug-elution port formed therein, and wherein the lead further includes a monolithic controlled release device disposed proximal to the annular face of the electrode.

15. A lead in accordance with claim 13, wherein at least one of the plurality of conductive radially-oriented segments disposed perpendicularly about the distal end of the tip electrode have a platinized, porous sintered coating disposed thereon.